What is the BCAX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Bicara Therapeutics Inc. Common Stock (BCAX) price will be around $13.17 in the next 2 weeks. This means it will decrease by -6.360597439544817 from the last closing price. This prediction may vary from other time period filters for BCAX stock.

What can be the highest Possible price of BCAX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BCAX can achieve the highest price of $13.84 which is -1.5832763054870822 lower than last closing price. This prediction may vary from other time period filters for BCAX stock.

What can be the lowest Possible price of BCAX stock in next 2 weeks?

As per the forecast and algorithmic analysis, BCAX stock price can be as low as $12.50 which is -11.114002294833615 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BCAX stock.

Will BCAX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that BCAX stock will lose-6.360597439544817 in the next 2 weeks. This prediction may vary from other time period filters for BCAX stock.

What is BCAX stock last closing price?

Last closing price of BCAX stock was $14.06.

What is BCAX stock price prediction?

BCAX stock price prediction means predicting the future closing prices of BCAX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BCAX stock in a certain time period.

How we predict BCAX stock future prices?

If you are searching for BCAX stock forecast, analysis or price prediction, then you might be wondering what Bicara Therapeutics Inc. Common Stock (BCAX) will do in the future. Our BCAX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BCAX price prediction will likely answer most of your questions.

How frequent we update BCAX stock predictions?

We are updating the forecasts for the BCAX stock on daily basis.

Is using ML forecasting for BCAX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BCAX stock same for all the time periods?

No, the prediction for BCAX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Bicara Therapeutics Inc. Common Stock Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$14.06-16.85%Since 2 Weeks

Predicted Price$13.17-6.36%For 2 Weeks

Upper Predicted Price$13.84-1.58%For 2 Weeks

Lower Predicted Price$12.50-11.11%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BCAX will decline by -6.36% over the next 2 Weeks and hit $13.17 by Thursday, February 26, 2026. In that time frame, BCAX's share price is expected to range between $12.50 and $13.84.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 26, 2026	12.50	13.17	13.84
Feb 25, 2026	12.97	13.66	14.30
Feb 24, 2026	12.79	13.42	14.11
Feb 23, 2026	12.64	13.32	14.00
Feb 20, 2026	13.09	13.71	14.32
Feb 19, 2026	13.00	13.67	14.32
Feb 18, 2026	13.55	14.17	14.89
Feb 17, 2026	13.30	13.93	14.62
Feb 16, 2026	13.16	13.83	14.53
Feb 13, 2026	13.57	14.21	14.84

BCAX shares fell -5.00% in Thursday, February 12, 2026's trading session, dropping from a previous close of $14.80 to move at $14.06. The stock demonstrated notable intraday movement (see BCAX's key stats for a full breakdown), fluctuating between $13.80 and $14.85, a +7.61% trading range. While recent weeks have seen some volatility, BCAX has managed to secure a -16.31% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 387.04K shares changing hands, 192.54K more than the previous session. This amounted to $5.44M in total market activity.

Will BCAX Continue Its Downward Trend?

According to analyst ratings and projections for BCAX, Bicara Therapeutics Inc. Common Stock shares are anticipated to decrease by -1.61%, potentially reaching $13.84 per share by February 26, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCAX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the BCAX stock forecast, now is not the best time to buy BCAX stock because its current trading price is +6.79% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCAX covering social and institutional perspectives.

BCAX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BCAX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 23.31% to 36.12%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 45.90%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.37%, maintains a neutral outlook for the long term. Insights into BCAX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Bicara Therapeutics Common Stock Short-Term Forecasts

BCAX Forecast For Next 5 Days

Our algorithm anticipates Bicara Therapeutics Common Stock (BCAX) stock could hit $16.04 by Feb 19, 2026. This represents a +14.07% fall from today's price, following a -4.07% change over the past five days.

BCAX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Bicara Therapeutics Inc. Common Stock (BCAX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $15.85, which would mean a +12.73% increase from the current price of $14.06. Projections for this period range from a high of $18.09 to a low of $13.22.

BCAX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Bicara Therapeutics Common Stock's price over the next three months point to a rise. BCAX stock is expected to peak at $57.42 on May 04, 2026 after potentially dipping to $24.07 on Feb 13, 2026. On average, BCAX is likely to trade around $42.27 in the coming 90 days.

Bicara Therapeutics Common Stock Stock Forecast 2025

Based on our predictive models, Bicara Therapeutics Common Stock (BCAX) is expected to trade between $24.07 and $57.42 throughout 2026. This would result in an average price of $42.20, potentially offering investors a +200.14% return from current levels.

Bicara Therapeutics Inc. Common Stock Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, Bicara Therapeutics Inc. Common Stock (BCAX) is positioned to show a strong performance in February 2026. The price is predicted to move between $24.07 and $36.76, settling at an average of $28.94. This could translate to a +105.83% gain.

March 2026

Based on current market signals, Bicara Therapeutics Inc. Common Stock is projected to trend march 2026. We forecast a trading range from $33.78 to $52.39, with a likely average price of $45.38. Investors could expect a potential return of +222.76%.

April 2026

Our predictive algorithms indicate Bicara Therapeutics Inc. Common Stock stock may see a shift in April 2026. The expected range spans $29.39–$57.09, with an average target of $40.99. This represents a positive outlook and a possible gain of +191.54%.

May 2026

Analyzing established trends, Bicara Therapeutics Inc. Common Stock looks set to move in May 2026. Projections place the stock between $41.37 and $57.42, averaging around $49.17. This suggests a +249.72% gain from current levels.

June 2026

Market indicators suggest Bicara Therapeutics Inc. Common Stock could experience notable changes during June 2026. Prices could fluctuate within $36.28 to $43.72, with a midpoint forecast of $40.94. The stock might deliver a +191.18% gain.

July 2026

Forecasting for July 2026, models estimate that Bicara Therapeutics Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $25.08 and $43.59, averaging $32.00. This signals a positive trajectory with potential returns around +127.60%.

August 2026

According to our latest forecast models, Bicara Therapeutics Inc. Common Stock (BCAX) is positioned to show a strong performance in August 2026. The price is predicted to move between $31.74 and $49.45, settling at an average of $42.29. This could translate to a +200.78% gain.

September 2026

Based on current market signals, Bicara Therapeutics Inc. Common Stock is projected to trend september 2026. We forecast a trading range from $28.73 to $48.55, with a likely average price of $36.70. Investors could expect a potential return of +161.02%.

October 2026

Our predictive algorithms indicate Bicara Therapeutics Inc. Common Stock stock may see a shift in October 2026. The expected range spans $42.97–$55.94, with an average target of $50.89. This represents a positive outlook and a possible gain of +261.95%.

November 2026

Analyzing established trends, Bicara Therapeutics Inc. Common Stock looks set to move in November 2026. Projections place the stock between $40.98 and $56.59, averaging around $48.65. This suggests a +246.02% gain from current levels.

December 2026

Market indicators suggest Bicara Therapeutics Inc. Common Stock could experience notable changes during December 2026. Prices could fluctuate within $34.21 to $54.16, with a midpoint forecast of $42.62. The stock might deliver a +203.13% gain.

January 2027

Forecasting for January 2027, models estimate that Bicara Therapeutics Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $34.18 and $58.05, averaging $47.01. This signals a positive trajectory with potential returns around +234.35%.

February 2027

According to our latest forecast models, Bicara Therapeutics Inc. Common Stock (BCAX) is positioned to show a strong performance in February 2027. The price is predicted to move between $29.77 and $35.25, settling at an average of $31.61. This could translate to a +124.82% gain.

BCAX's history of dividends and stock splits also plays a role in long-term investor confidence.